Jaguar Health, Inc. — Form 8-K
Filed September 15, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 8/100
What the filing says
Jaguar Health, Inc. (market cap ~$3.8M) implemented a reverse stock split at a ratio of 1-for-15, effective September 17, 2026, to maintain compliance with Nasdaq listing standards. The split was approved by stockholders at an April 2026 Special Meeting. No dollar amounts, debt, assets, or business fundamentals changed; this is a purely mechanical share restructuring.
Why this rating
Reverse split is routine, non-dilutive capital structure adjustment. No operational, financial, or strategic change. Neutral for long-term value but signals potential delisting risk.
See more from September 15, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.